The Trump administration is preparing to implement a controversial Medicare pilot program that could significantly reshape how medical care decisions are made for millions of Americans. The initiative—set to begin in January 2026—will mark the first time that patients enrolled in traditional Medicare, not just Medicare Advantage, will be required to obtain prior authorization before undergoing certain procedures.
This pilot program will initially launch in six states—Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. According to the Centers for Medicare & Medicaid Services (CMS), the program’s stated goal is to reduce fraud, waste, and unnecessary spending within one of the government’s most expensive programs. Medicare currently consumes nearly a quarter of the federal budget, making it a central focus of cost-cutting reforms championed by former President Donald Trump.
What Makes This Program Different?
Unlike existing Medicare processes, this pilot will rely heavily on private contractors and artificial intelligence tools to screen requests for care. While CMS has emphasized that licensed clinicians will ultimately make the final decisions on denials, the initial determinations will be strongly influenced by automated systems.
Critics have raised concerns that this added layer of approval could create barriers to timely care—particularly for seniors managing chronic and complex conditions. Many of the targeted procedures are commonly used to treat illnesses that disproportionately affect older Americans.
Procedures Impacted by the Pilot Program
According to reporting by New York Times journalist Teddy Rosenbluth, the pilot will require prior authorization for the following procedures starting in 2026:
-
Electrical Nerve Stimulators
-
Sacral Nerve Stimulation for Urinary Incontinence
-
Phrenic Nerve Stimulator
-
Deep Brain Stimulation for Essential Tremor and Parkinson’s Disease
-
Vagus Nerve Stimulation
-
Induced Lesions of Nerve Tracts
-
Epidural Steroid Injections for Pain Management (excluding facet joint injections)
-
Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
-
Cervical Fusion
-
Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee
-
Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
-
Incontinence Control Devices
-
Diagnosis and Treatment of Impotence
-
Percutaneous Image-Guided Lumbar Decompression for Spinal Stenosis
-
Skin and Tissue Substitutes (in states with active Local Coverage Determinations)
Why This Matters for Patients
For millions of seniors and individuals with disabilities who rely on Medicare, these changes could have far-reaching consequences. While CMS frames the initiative as a cost-control measure, patients and providers fear it could mean delayed or denied access to necessary treatments—particularly when AI-driven systems make the first judgment calls.
What You Should Do
If you or a loved one rely on Medicare, it is crucial to stay informed about how this pilot program may affect your care. Patients should:
-
Speak with healthcare providers about how prior authorization could impact treatment plans.
-
Monitor official CMS updates as the program rolls out.
-
Advocate for transparency and accountability in how decisions are made.
Healthcare reform always sparks debate, but with so much at stake, beneficiaries cannot afford to be passive. Your awareness and voice will be essential in shaping the future of Medicare.